Home » Tender for Successful Delivery Of A Medicinal Product Containing The Active Substance Nivolumab As Part Of A Non-commercial Clinical Trial: "efficacy And Tolerability Of N-avd Compared To Brecadd In Patients With Advanced Hodgkin Lymphoma (n-brave)", Poland
Tender Notice
Tender Notice
Tender TI Ref No
531704101
Tender Date
17 Apr 2026
Tender Description
Tender for Successful Delivery Of A Medicinal Product Containing The Active Substance Nivolumab As Part Of A Non-commercial Clinical Trial: "efficacy And Tolerability Of N-avd Compared To Brecadd In Patients With Advanced Hodgkin Lymphoma (n-brave)"